Literature DB >> 23921951

Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.

Amanda Croft1, Kwang H Tay2, Suzanah C Boyd3, Su T Guo4, Chen C Jiang2, Fritz Lai2, Hsin-Yi Tseng2, Lei Jin2, Helen Rizos3, Peter Hersey5, Xu D Zhang6.   

Abstract

Cancer cells commonly undergo chronic endoplasmic reticulum (ER) stress, to which the cells have to adapt for survival and proliferation. We report here that in melanoma cells intrinsic activation of the ER stress response/unfolded protein response (UPR) is, at least in part, caused by increased outputs of protein synthesis driven by oncogenic activation of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) and promotes proliferation and protects against apoptosis induced by acute ER stress. Inhibition of oncogenic BRAF(V600E) or MEK-attenuated activation of inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6) signaling of the UPR in melanoma cells. This was associated with decreased phosphorylation of eukaryotic initiation factor 4E (eIF4E) and nascent protein synthesis and was recapitulated by knockdown of eIF4E. In line with this, introduction of BRAF(V600E) into melanocytes led to increases in eIF4E phosphorylation and protein production and triggered activation of the UPR. Similar to knockdown of glucose-regulated protein 78 (GRP78), inhibition of XBP1 decelerated melanoma cell proliferation and enhanced apoptosis induced by the pharmacological ER stress inducers tunicamycin and thapasigargin. Collectively, these results reveal that potentiation of adaptation to chronic ER stress is another mechanism by which oncogenic activation of the MEK/ERK pathway promotes the pathogenesis of melanoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921951     DOI: 10.1038/jid.2013.325

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  60 in total

1.  IRE1 signaling affects cell fate during the unfolded protein response.

Authors:  Jonathan H Lin; Han Li; Douglas Yasumura; Hannah R Cohen; Chao Zhang; Barbara Panning; Kevan M Shokat; Matthew M Lavail; Peter Walter
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

2.  IGFBP7 is not required for B-RAF-induced melanocyte senescence.

Authors:  Lyndee L Scurr; Gulietta M Pupo; Therese M Becker; Ken Lai; David Schrama; Sebastian Haferkamp; Mal Irvine; Richard A Scolyer; Graham J Mann; Jürgen C Becker; Richard F Kefford; Helen Rizos
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

Review 3.  Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.

Authors:  Peter Hersey; L Zhuang; X D Zhang
Journal:  Int Rev Cytol       Date:  2006

4.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Authors:  Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Journal:  Mol Oncol       Date:  2007-12-28       Impact factor: 6.603

5.  Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.

Authors:  Chen Chen Jiang; Keryn Lucas; Kelly A Avery-Kiejda; Margaret Wade; Charles E deBock; Rick F Thorne; John Allen; Peter Hersey; Xu Dong Zhang
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

6.  Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.

Authors:  Daniela Beck; Heike Niessner; Keiran S M Smalley; Keith Flaherty; Kim H T Paraiso; Christian Busch; Tobias Sinnberg; Sophie Vasseur; Juan Lucio Iovanna; Stefan Drießen; Björn Stork; Sebastian Wesselborg; Martin Schaller; Tilo Biedermann; Jürgen Bauer; Konstantinos Lasithiotakis; Benjamin Weide; Jürgen Eberle; Birgit Schittek; Dirk Schadendorf; Claus Garbe; Dagmar Kulms; Friedegund Meier
Journal:  Sci Signal       Date:  2013-01-29       Impact factor: 8.192

Review 7.  GRP78 induction in cancer: therapeutic and prognostic implications.

Authors:  Amy S Lee
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 8.  Translation regulation as a therapeutic target in cancer.

Authors:  Michal Grzmil; Brian A Hemmings
Journal:  Cancer Res       Date:  2012-07-31       Impact factor: 12.701

Review 9.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

10.  Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress.

Authors:  K H Tay; L Jin; H-Y Tseng; C C Jiang; Y Ye; R F Thorne; T Liu; S T Guo; N M Verrills; P Hersey; X D Zhang
Journal:  Cell Death Dis       Date:  2012-06-28       Impact factor: 8.469

View more
  43 in total

1.  Atypical amplification of chromosome region 22q12 in melanoma: A case report.

Authors:  Giuseppina Liguori; Monica Cantile; Francesca Collina; Laura Marra; Anna DE Chiara; Renato Franco; Michele Caraglia; Gerardo Botti; Mirella D'Andrea; Giovanni Francesco Nicoletti
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

2.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

Review 3.  Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?

Authors:  David S Hill; Penny E Lovat; Nikolas K Haass
Journal:  Melanoma Manag       Date:  2014-12-04

Review 4.  Developing anti-neoplastic biotherapeutics against eIF4F.

Authors:  Jutta Steinberger; Jennifer Chu; Rayelle Itoua Maïga; Katia Sleiman; Jerry Pelletier
Journal:  Cell Mol Life Sci       Date:  2016-12-21       Impact factor: 9.261

Review 5.  Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy.

Authors:  Feven Tameire; Ioannis I Verginadis; Constantinos Koumenis
Journal:  Semin Cancer Biol       Date:  2015-04-25       Impact factor: 15.707

Review 6.  Therapeutic interventions to disrupt the protein synthetic machinery in melanoma.

Authors:  Gregory R Kardos; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2015-09       Impact factor: 4.693

Review 7.  Endoplasmic reticulum quality control in cancer: Friend or foe.

Authors:  Hana Kim; Asmita Bhattacharya; Ling Qi
Journal:  Semin Cancer Biol       Date:  2015-03-18       Impact factor: 15.707

Review 8.  Emerging tale of UPR and cancer: an essentiality for malignancy.

Authors:  Younis Mohammad Hazari; Arif Bashir; Ehtisham Ul Haq; Khalid Majid Fazili
Journal:  Tumour Biol       Date:  2016-09-14

Review 9.  Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatment.

Authors:  Mohamed Hassan; Denis Selimovic; Matthias Hannig; Youssef Haikel; Robert T Brodell; Mossaad Megahed
Journal:  World J Exp Med       Date:  2015-11-20

10.  Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma.

Authors:  Akira Shimizu; Kyoichi Kaira; Masahito Yasuda; Takayuki Asao; Osamu Ishikawa
Journal:  Pathol Oncol Res       Date:  2016-08-08       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.